Our Work
Latham & Watkins LLP Represents SoftBank Vision Fund 2 in Opentrons’ US$200 Million Series C Financing
September 23, 2021
A Bay Area-based team advises the lead investor in the financing of the company aiming to transform healthcare and life sciences with vertically integrated, low-cost solutions.
Opentrons Labworks Inc., the developer of integrated lab platforms that serve life science and healthcare customers, has announced SoftBank Vision Fund 2 has led the company's US$200 million Series C investment with participation by Khosla Ventures.
Latham & Watkins LLP represents SoftBank Vision Fund 2 in the financing with a corporate deal team led by Bay Area partners Saad Khanani and Ben Potter, with Bay Area associates Sally Wong and Adam Zuckerman.